{
    "pmcid": "11277559",
    "qa_pairs": {
        "How do nanobodies contribute to allergy research according to the summary?": [
            "They can block IgE-allergen interactions, reducing allergic reactions.",
            "They enhance the production of IgE to improve immune response.",
            "They increase the release of histamines to counteract allergens.",
            "They bind to allergens to increase their immunogenicity."
        ],
        "What future direction is proposed for the administration of nanobodies in respiratory diseases?": [
            "Delivering nanobodies via inhalation for rapid and localized action.",
            "Administering nanobodies intravenously for systemic distribution.",
            "Using oral formulations to enhance patient compliance.",
            "Applying nanobodies topically to reduce respiratory symptoms."
        ],
        "What is a critical design consideration for SARS-CoV-2 nanobody binders mentioned in the summary?": [
            "Specificity to the virus's spike protein is critical.",
            "They must target the nucleocapsid protein for effective neutralization.",
            "They should primarily bind to the viral RNA for inhibition.",
            "Cross-reactivity with influenza viruses is essential."
        ],
        "What is a key advantage of nanobodies over conventional antibodies in terms of production and stability?": [
            "Their small size allows for easy production and high stability.",
            "They can be produced in mammalian cell systems with high yield.",
            "They have a longer half-life in vivo without modifications.",
            "Their complex structure allows for higher specificity."
        ],
        "What strategy is suggested to extend the in vivo half-life of nanobodies?": [
            "PEGylation, fusion to albumin, or engineering multimeric forms.",
            "Increasing their molecular weight through glycosylation.",
            "Using lipid nanoparticles for encapsulation.",
            "Administering them with adjuvants to slow clearance."
        ]
    }
}